CD34 and Duchenne muscular dystrophy: In this study, we noted a similar trend in people with DMD on chronic GCs relative to healthy controls, including reduced concentrations of serum PDGF-BB and percentages of circulating POCs, SPCs, and CD34+ cells in people with DMD treated with chronic GCs relative to healthy controls.